D. Cataldo (Liege, Belgium), R. Zinsky (Wiesbaden, Germany), R. Mroz (Bialystok, Poland), A. Kempa (Stuttgart, Germany)
Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis
A. J. Ruiz Reina, M. Gonzalez, E. Vazquez, R. I. Aguilar Perez Grovas, I. Vazquez Rico, T. Garcia Barrera, J. Gravalos Guzman, J. L. Sanchez Ramos, J. A. Maldonado Perez, J. L. Gomez Ariza, A. Pereira Vega (Huelva, Spain)
|   |
CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
L. Barrera, R. Morales, A. Rodríguez, Y. Dorantes, M. D. L. A. García, M. F. Salinas, E. Montes, A. Gómez, J. L. Bañales, O. Arrieta (Mexico City, Mexico)
| |
pDC induced Treg proliferation through PD-1/PD-L1 signal and promote tumor immune escape of lung cancer with MPE
C. Mu, G. Zhang, J. Huang, B. Qi (Suzhou, China)
| |
Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model
J. W. Kim, C. D. Yeo, J. M. Lee, H. H. Kang, S. H. Lee (Seoul, Republic Of Korea)
| |
Functional impairment of NK cells in non-small-cell lung cancer
L. Barrera, A. Gómez-Gallegos, A. García-Vicente, M. Herrera, O. Arrieta (Mexico City, Mexico)
| |
The effects of hypoxia on the expression of MMP-2, MMP-9 in human lung adenocarcinoma A549 cells
Y. L. Lee, W. E. Cheng, S. C. Chen, C. Y. Chen, C. M. Shih (Taichung, Taiwan)
| |
Antitumor effect of a humanized antibody against aminopeptidase N in mouse tumor models.
S. Akita, N. Hattori, K. Fujitaka, Y. Haruta, H. Murai, N. Kohno (Hiroshima, Japan)
| |
Clinical significance of erythropoietin (Epo) and its receptor (EpoR) in non-small cell lung carcinoma
A. Korzeniewska, A. Halon, R. Jankowska (Wroclaw, Poland)
| |
Metabolomic analysis of serum samples from patients with lung cancer
E. Vázquez-Gandullo, M. González, A. J. Ruiz-Reina, T. García-Barrena, R. Aguilar Pérez-Grovas, J. Grávalos-Guzmán, J. L. Sánchez-Ramos, J. A. Maldonado-Pérez, J. L. Gómez-Ariza, A. Pereira-Vega (Huelva, Spain)
| |
Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report
T. Wandtke, J. Wielikdzien, C. Rybacki, G. Przybylski, J. Golinska, B. Przybyslawski, P. Kopinski (Bydgoszcz, Poland)
| |
Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC)
A. Gizycka, J. Chorostowska-Wynimko, C. Rybacki, A. Dyczek, T. Wandtke, P. Kopinski (Warsaw, Bydgoszcz, Cracow, Poland)
| |
Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
M. Petrovic, I. Cekerevac, Z. Lazic, V. Cupurdija, D. Petrovic, R. Vucic, G. Kostic (Kragujevac, Republic Of Serbia)
| |
Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer
A. Kowal, A. Wisniewski, P. Kusnierczyk, R. Jankowska (Wroclaw, Poland)
| |
Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer cells in mice
R. Takahashi, H. Amano, M. Majima (Kanagawa, Japan)
| |
Prognostic value of EGFR mutation in NSCLC in surgical stage
A. Gonçalves, A. Antunes, S. Campainha, A. Barroso, S. Conde, J. Miranda, B. Parente (Vila Nova de Gaia, Portugal)
| |
Gene expression of EGFR, MINA53,MEN1 and MTOR in NSCLCs
D. Marinova, Y. Slavova, D. Kachakova, G. Stancheva, A. Mitkova, R. Kaneva, D. Petrov, V. Mitev (Sofia, Bulgaria)
| |
Investigation of survivin gene expression in non small cell lung cancer
E. Aynaci, S. Kamat, Y. Müsteri Oltulu, P. Yildiz, E. Coskunpinar, N. Akanil, O. Kum, I. Yaylim (Istanbul, Turkey)
| |
The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer
E. Coskunpinar, N. Akkaya, P. Yildiz, Y. Musteri Oltulu, E. Aynaci, T. Isbir, I. Yaylim (Istanbul, Turkey)
| |
Expression of interleukin-27 (IL-27) in mixed mononuclear-tumor cells culture
J. Wielikdzien, T. Wandtke, E. Wedrowska, L. Gackowska, A. Goede, P. Kopinski (Bydgoszcz, Poland)
| |